Initializing...

This conversation is about to expire due to inactivity.

Click “Continue” to extend your conversation and continue chatting.

This conversation has expired due to inactivity.

Refresh this page to start a new conversation.

Homepage Illustration

The University of Pittsburgh Clinical and Translational Science Institute (CTSI) is an integral part of the National Institutes of Health (NIH) nationwide network that provides the support necessary to bridge the gap between innovative approaches to research and effective clinical and public health practice and policy.

EXPLORE RESEARCH SERVICES
CTSI Users

About Us

We help synthesize University-wide programs and new initiatives to promote a more comprehensive understanding of the tangible benefits to health practice that can be realized from clinical and translational research. We are innovation leaders who take great pride in the number of successful projects with which we have assisted.

WHAT WE DO

Guides & Tools

A collection of research-focused guides and tools to help with all aspects of the research process.

EXPLORE GUIDES & TOOLS

Funding

The latest information about funding announcements, opportunities, support and resources.

LEARN ABOUT FUNDING

Education & Training

Find out about ICRE degree programs, awards, fellowships, and scholarships, in addition to information about seminars and workshops.

EDUCATION & TRAINING INFO

Meet Our Team

Our research facilitators and Core divisions offer a wide array of services and specialist knowledge. Together, they can help your research project reach its full potential.

I Need Help

Get in contact with CTSI to learn more about research services, guides and tools, funding opportunities, and more.

CONTACT US
I need help

Insights:
Participant Recruitment and Engagement

Pitt+Me Logo

Pitt+Me Registry, a database of more than 200,000 adult and pediatric participants, is an innovative voluntary database of individuals who have consented to be contacted for potential participation in research studies. The registry’s novel software matches participants with studies for which they may be eligible.